CA983938A - (+)-cis-1,3-dibenzyl-hexahydro-1h-furo (3,4-d) imidazole-2,4-dione - Google Patents

(+)-cis-1,3-dibenzyl-hexahydro-1h-furo (3,4-d) imidazole-2,4-dione

Info

Publication number
CA983938A
CA983938A CA098,431A CA98431A CA983938A CA 983938 A CA983938 A CA 983938A CA 98431 A CA98431 A CA 98431A CA 983938 A CA983938 A CA 983938A
Authority
CA
Canada
Prior art keywords
furo
dibenzyl
hexahydro
dione
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA098,431A
Other languages
English (en)
Inventor
Jean P. Zimmermann
Max Gerecke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA983938A publication Critical patent/CA983938A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA098,431A 1969-11-29 1970-11-18 (+)-cis-1,3-dibenzyl-hexahydro-1h-furo (3,4-d) imidazole-2,4-dione Expired CA983938A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1777269A CH565798A5 (xx) 1969-11-29 1969-11-29

Publications (1)

Publication Number Publication Date
CA983938A true CA983938A (en) 1976-02-17

Family

ID=4427992

Family Applications (1)

Application Number Title Priority Date Filing Date
CA098,431A Expired CA983938A (en) 1969-11-29 1970-11-18 (+)-cis-1,3-dibenzyl-hexahydro-1h-furo (3,4-d) imidazole-2,4-dione

Country Status (10)

Country Link
JP (1) JPS4932551B1 (xx)
BE (1) BE759512A (xx)
CA (1) CA983938A (xx)
CH (1) CH565798A5 (xx)
DE (1) DE2058248C3 (xx)
DK (1) DK143109C (xx)
FR (1) FR2077539B1 (xx)
GB (1) GB1287839A (xx)
NL (1) NL159385B (xx)
SE (1) SE391718B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0081047B1 (de) * 1981-12-07 1985-12-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung eines optisch aktiven Lactons und neue Ausgangsprodukte in diesem Verfahren
DE3150723A1 (de) * 1981-12-22 1983-06-30 Basf Ag, 6700 Ludwigshafen Verbessertes verfahren zur herstellung von 1,3-disubstituierten 4,5-cis-dicarboxy-2-imidazolidonen
CH670644A5 (xx) * 1986-12-18 1989-06-30 Lonza Ag
CH671227A5 (xx) * 1986-12-02 1989-08-15 Lonza Ag
US5162540A (en) * 1986-12-18 1992-11-10 Lonza Ltd. Process for the production of (+) biotin
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
FI935609A (fi) * 1992-12-18 1994-06-19 Lonza Ag Dihydrofuroimidatsolijohdannaisten asymmetrinen hydraus
CA2134441A1 (en) * 1993-04-20 1994-10-27 Martin Eyer Asymmetric hydrogenation of furoimidazole derivatives
CA2122511A1 (en) * 1993-05-14 1994-11-15 John Mcgarrity Asymmetric hydrogenation of furoimidazole derivatives
DE10033284A1 (de) * 2000-07-07 2002-01-17 Merck Patent Gmbh Verfahren zur Herstellung von (+)-Biotin
TW200300676A (en) 2001-12-04 2003-06-16 Tanabe Seiyaku Co Biotin intermediate and its production
CN113121549B (zh) * 2019-12-31 2022-08-26 江西天新药业股份有限公司 立体选择性合成手性内酯的方法和手性化合物及其应用

Also Published As

Publication number Publication date
CH565798A5 (xx) 1975-08-29
NL7015355A (xx) 1971-06-02
DE2058248C3 (de) 1980-12-18
JPS4932551B1 (xx) 1974-08-31
FR2077539A1 (xx) 1971-10-29
DK143109C (da) 1981-09-21
DK143109B (da) 1981-03-30
GB1287839A (xx) 1972-09-06
FR2077539B1 (xx) 1973-02-02
BE759512A (fr) 1971-05-27
NL159385B (nl) 1979-02-15
DE2058248B2 (de) 1980-04-10
DE2058248A1 (de) 1971-06-09
SE391718B (sv) 1977-02-28

Similar Documents

Publication Publication Date Title
CA982591A (en) Racemic and (+)-cis-1,3-dibenzyl-hexahydro-1h-thieno-(3,4-d)imidazole-2,4-dione
CA954522A (en) Amidine derivatives
CA956944A (en) Uracil derivatives
CA983938A (en) (+)-cis-1,3-dibenzyl-hexahydro-1h-furo (3,4-d) imidazole-2,4-dione
CA931568A (en) Pyrazolo(3,4-d)pyrimidines
AU4875672A (en) Thiazolo %5,4-d<pyrimidines
CA961040A (en) 6-substituted-indolo (1,2-c)quinazolines
AU2314970A (en) Pyrimidine derivatives
AU1108070A (en) Pyrimidine derivatives
AU2315570A (en) Pyrimidine derivatives
CA936162A (en) Pesticidal pyrimidine derivatives
CA817888A (en) 6,7-dihydro-5h-pyrrolo(3,4-d) pyrimidines
CA814451A (en) Pyrazolo(3,4-d)pyrimidine derivatives
AU445475B2 (en) 6 substituted indolo(1, 2 c)quinazolines
CA932736A (en) Pyrimidine derivatives
AU429206B2 (en) 1, 5 benzodiazepine 2, 4-dione derivatives
CA924719A (en) Heterocyclic compounds
AU2107270A (en) 6 substituted indolo(1, 2 c)quinazolines
AU1107970A (en) Pyrimidine derivatives
AU5795469A (en) 1, 5 benzodiazepine 2, 4-dione derivatives
CA815016A (en) 7-ureido-2,4-dioxo-1,2,3,4,5,6-hexahy-dropyrido-(2,3-d)pyrimidines
CA780434A (en) 4-substituted-1-alkyl-6-(5-nitro-2-furyl)-1h-pyrazolo(3,4-d) pyrimidines
CA811725A (en) Naphth-(2,3-b)indolizine-6,11-dione-12-carboxyarylamide compounds
CA780436A (en) 6-phenyl-2,3,6,7-tetrahydro-4h-pyrimido(1,2-c)quinazoline
CA812827A (en) Pyrrolo (2,3-b)-indoles